Position in RGNX
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$129,881
-$62,762 QoQ
Shares Held
15,499
+15.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Diversified Trust Co holds $33,471,666 across 42 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
25,991 | $6,932,319 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
39,222 | $2,367,439 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
19,050 | $2,230,183 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
35,281 | $2,004,313 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,481 | $1,547,002 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
41,966 | $1,401,244 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
66,194 | $1,238,489 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
46,194 | $1,168,708 |
All Filings in RGNX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $129,881 | 15,499 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $192,643 | 13,378 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $103,862 | 10,763 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $88,364 | 10,763 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $74,016 | 10,352 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $80,020 | 10,352 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $108,592 | 10,352 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $121,118 | 10,352 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||